Federal contract award
75N91019F00140
HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N91019D00024 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $10.9M |
| Current contract value | $10.9M |
| Potential contract value / ceiling | $12.2M |
| Start date | Sep 16, 2019 |
| Current end date | Sep 2, 2027 |
| Potential end date | Sep 2, 2027 |
| Latest award activity | Aug 29, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 13 of 13 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 8, 2026 | P00012 | $-1.7M | NEURESTA DRUG SUBSTANCE MANUFACTURING |
| Aug 29, 2025 | P00011 | $0 | NEURESTA DRUG SUBSTANCE MANUFACTURING |
| Sep 13, 2024 | P00010 | $1.4K | NEURESTA DRUG SUBSTANCE MANUFACTURING |
| Sep 3, 2024 | P00008 | $-94.5K | NEURESTA DRUG SUBSTANCE MANUFACTURING |
| Sep 3, 2024 | P00009 | $2.8M | NEURESTA DRUG SUBSTANCE MANUFACTURING |
| Sep 22, 2023 | P00007 | $1.6M | HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT |
| Feb 22, 2023 | P00006 | $0 | HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT |
| Nov 22, 2022 | P00005 | $0 | HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT |
| Nov 3, 2022 | P00004 | $0 | HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT |
| Sep 15, 2021 | P00003 | $4.3M | HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT |
| Aug 9, 2021 | P00002 | $0 | HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT |
| May 20, 2020 | P00001 | $0 | HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT |
| Sep 14, 2019 | 0 | $2.3M | HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT |
Estimated positioning window
Oct 25, 2026 – Mar 2, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-09-02 (312 days from calculation)
- +35 points
- 240 historical awards in this buyer and category group
- +15 points
- 13 recorded award transactions
- +10 points
- Latest award action: 2025-08-29
- +0 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.